CrystalGenomics, Inc. - Product Pipeline Review – 2015 Now Available at iData Insights CrystalGenomics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct s, CrystalGenomics, Inc. - Product Pipeline Review - 2015 , provides an overview of the CrystalGenomics, Inc. s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of CrystalGenomics, Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of CrystalGenomics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of CrystalGenomics, Inc. s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product s developmental history and major milestones - Special feature on outlicensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects Latest company statement - Latest news and deals relating to the CrystalGenomics, Inc. s pipeline products Reasons to buy - Evaluate CrystalGenomics, Inc. s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of CrystalGenomics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the CrystalGenomics, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of CrystalGenomics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of CrystalGenomics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of CrystalGenomics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124193/crystalgenomics-inc-product-pipeline-review-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124193/crystalgenomics-inc-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 CrystalGenomics, Inc. Snapshot 5 CrystalGenomics, Inc. Overview 5 Key Information 5 Key Facts 5 CrystalGenomics, Inc.
Research and Development Overview
1
6 Key Therapeutic Areas 6 CrystalGenomics, Inc. Pipeline Products Monotherapy 10 Pipeline Products
Pipeline Review 9 Pipeline Products by Stage of Development 9
Partnered Products
11 Partnered Products/Combination Treatment Modalities 12 CrystalGenomics, Inc.
Pipeline Products Glance
13 CrystalGenomics, Inc.
Clinical Stage Pipeline Products
13 Phase II Products/Combination Treatment Modalities 13 CrystalGenomics, Inc.
Early Stage Pipeline Products
14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 CrystalGenomics, Inc.
Drug Profiles
16 CG-200745 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 CG-400549 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 CG-0009 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 CG-026806 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 CG-036806 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 CG-103065 21 Product Description 21 Mechanism of Action
2
21 R&D Progress 21 polmacoxib 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Small Molecule to Target Metalloproteinases for Undisclosed Indication 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecule to Target Nuclear Hormone Receptors for Undisclosed Indication 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecule to Target Phosphodiesterases for Undisclosed Indication 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 CrystalGenomics, Inc.
Pipeline Analysis
27 CrystalGenomics, Inc.
Pipeline Products by Target
27 CrystalGenomics, Inc.
Pipeline Products by Route of Administration
28 CrystalGenomics, Inc.
Pipeline Products by Molecule Type
29 CrystalGenomics, Inc.
Pipeline Products by Mechanism of Action
30 CrystalGenomics, Inc.
Recent Pipeline Updates
31 CrystalGenomics, Inc.
Dormant Projects
34 CrystalGenomics, Inc.
Locations And Subsidiaries 35 Head Office
35 Other Locations & Subsidiaries 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us
3
36 Disclaimer Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124193/crystalgenomics-inc-productpipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
4